SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology ($GSIT) is trending due to news of a U.S. Army contract for its Gemini-II technology, sparking excitement around its potential in edge AI computing. The community is discussing the significance of this contract, comparing it to industry giants like NVIDIA, and speculating about future partnerships and buyouts. Some traders are also noting a potential short squeeze due to the stock's thin float.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending after announcing plans to explore rare earth production at its U.S. mining sites, potentially making it a key player in America's push for critical mineral independence. The community is discussing the company's strategic shift from steel to strategic minerals, with some believing it's a smart move given China's tightening export controls, while others express skepticism and focus on debt reduction.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

REPL is experiencing a surge driven by news of the FDA accepting the resubmission of its Biologics License Application for RP1, a melanoma treatment. Community members are actively discussing price target upgrades and the potential for a short squeeze, while also weighing the possibility of future dilution. The stock's movement is also being compared to other trending tickers in the sector.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is trending due to positive data readouts for their KRAS G12D inhibitor, particularly in lung cancer, sparking discussions about its potential as a leading candidate and buyout target; community chatter also highlights analyst upgrades and speculation around short squeezes, with some emphasizing the company's long-term potential amid market volatility. The ESMO 2025 data for GFH375 has generated excitement, with many pointing out the high ORR and DCR figures.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending due to widespread outages reported across the platform, reportedly linked to issues with Amazon Web Services (AWS), sparking frustration and concerns among users who were unable to access their accounts and execute trades. The community is expressing distrust and contemplating switching to alternative brokerages, while also speculating about potential market manipulation during the outage. Despite the technical difficulties, the stock is experiencing high trading volume and price volatility, leading to discussions about its long-term potential.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix ($CRMD) is trending after reporting preliminary Q3 results and raising FY25 revenue guidance, leading to a surge in stock price. The community is actively discussing the company's profitability, potential for a short squeeze, and a possible acquisition by Pfizer. Positive real-world evidence and further catalysts are anticipated, while some investors express frustration with management decisions.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF (BTC) is trending as Bitcoin tests new highs, with community discussions focused on resistance levels and potential pullbacks. There's debate around its role as a safe haven asset compared to gold, with some highlighting its historical performance during times of economic uncertainty. Additionally, the ETF's correlation with other crypto-related stocks and the broader market is being closely monitored.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity (CELC) is trending following positive Phase 3 trial data for its breast cancer therapy, with the community actively discussing the potential for FDA approval and a possible buyout. The stock's significant pre-market surge has sparked conversations about its valuation and future prospects in the biotech sector. Community members are weighing the potential for continued gains against the possibility of a pullback.

PIMCO Dynamic Income Fund is a non-diversified, closed-end management investment company. Its seeks current income as a primary objective and capital appreciation as a secondary objective. The company was founded on January 19, 2011 and is headquartered in New York, NY.

PIMCO Dynamic Income Fund

PDI is trending as investors discuss its high dividend yield and potential benefits from future rate cuts, although some express concerns about its sustainability. Community members are actively debating strategies like DRIP and comparing PDI to similar CEFs and BDCs. Additionally, there's chatter regarding the timing of dividend payments and potential special distributions.

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

RAPT Therapeutics Inc

RAPT Therapeutics is trending following the announcement of positive topline data from its Phase 2 trial of RPT904 in Chronic Spontaneous Urticaria, sparking discussions about the drug's efficacy and potential. Community members are actively analyzing price levels for potential upside, while also weighing the news against the broader context of the company's pipeline and potential offerings. Some traders are noting the stock's strength and upside potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

professeure

Klinsmann

$ETHM 🚀 Why a Move to $100 scenario is Plausible? 
 1. Massive Ethereum Exposure
 • Backed by 400,000+ ETH (~$1.5B) — if ETH moves to $4,000+, the NAV of this entity balloons.
 • DYNX becomes a public proxy for ETH staking + yield (which no major ETF currently provides).
 2. Institutional Credibility
 • Kraken, Blockchain.com, Pantera Capital, and more behind this — not a meme SPAC, but a structured deal.
 • Andrew Keys (ex-ConsenSys) has real weight in Ethereum circles.
 3. Thin Float, High Demand
 • Tiny float (~22M shares), with much of the supply now in speculative or long-term hands.
 • In a bullish ETH market, the crowd will pile in for exposure.
 4. Narrative Power
 • First-of-its-kind, Ethereum-native public company.
 • Could become Wall Street’s “Ethereum Growth ETF”, even if unofficially. This deal makes $BMNR look like child play. $400M oppose to $1.5B $ETH.X $ETCG Treasury.